Title:
癌の治療のためのモノクローナル抗体
Document Type and Number:
Japanese Patent JP5843822
Kind Code:
B2
Abstract:
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing GT468, including tumor-related diseases such as breast cancer, lung cancer, gastric cancer, ovarian cancer, and hepatocellular cancer.
Inventors:
Sahin, Uguru
Koslovsky, Michael
Thulech, Ezrem
Koslovsky, Michael
Thulech, Ezrem
Application Number:
JP2013168465A
Publication Date:
January 13, 2016
Filing Date:
August 14, 2013
Export Citation:
Assignee:
Ganymed Pharmaceuticals AG
International Classes:
C07K16/30; A61K39/395; A61P35/00; A61P37/04; C12N5/10; C12N15/02
Foreign References:
| US20020065394 |
Other References:
CHEN JING et al,JOURNAL OF PEKING UNIVERSITY,HEALTH SCIENCES,2006年 4月18日,Vol. 38, No. 2,p. 124-127
Koslowski et al,Cancer Res,2007年10月 1日,Vol. 67, No. 19,p. 9528-9534
Silva Jr. et al,Cancer Immunity,2007年11月 6日,Vol. 7, p. 18
Koslowski et al,Cancer Res,2007年10月 1日,Vol. 67, No. 19,p. 9528-9534
Silva Jr. et al,Cancer Immunity,2007年11月 6日,Vol. 7, p. 18
Attorney, Agent or Firm:
Shinji Hayami